Nathalie Garnier-Viougeat

  • Citations Per Year
Learn More
Sir, Bevacizumab, a recombinant humanized monoclonal antibody against VEGF (rhuMAb VEGF, Avastin , Genentech, South San Francisco, CA), was approved as a treatment for metastatic renal cell carcinoma (RCC) [1]. However, no bevacizumab pharmacokinetic data are available for patients with renal failure. We report a pharmacokinetic study of bevacizumab in a(More)
  • 1